(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARGORNA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ARGORNA

ST13

US500000088770805

Class

5

Filing

88770805

Registration

6662188

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

04/21/2023

Trademark type

Word

Nice classes

5

Filing date

01/23/2020

Registration date

03/08/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/08/2022

Last transaction

04/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

22

Owner location

HUANGPU DISTRICT, GUANGZHOU, CN

Examiner

BATT, JAIME

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ARGORNA PHARMACEUTICALS LIMITED
GUANGZHOU RIBOBIO CO., LTD.

Representatives

Stacy L. Emhoff WALKER & JOCKE CO., LPA

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposes for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Pharmaceutical preparations for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Chemical-pharmaceutical preparations for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Drug delivery agents in the form of sterile liquidsterile freeze-dry powderemulsion or inhalation for medical purposes that provide controlled release of active ingredients for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Veterinary preparations for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm in catsdogshorseschicken and pigs; Medicines for veterinary purposes being preparations for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm in catsdogshorseschicken and pigs; Biological preparations for veterinary purposes for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm; Chemical preparations for veterinary purposes for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm; Preparations for destroying noxious animalspesticidesinsecticides; Preparations for destroying noxious plantsherbicides

Publications

History of USPTO decisions and trademark events.

33 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/21/2021

PUBO

PUBLISHED FOR OPPOSITION

12/21/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/01/2021

OTHE

CASE RETURNED TO EXAMINATION

09/23/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

09/23/2021

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

09/23/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/20/2021

APET

ASSIGNED TO PETITION STAFF

09/14/2021

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

09/07/2021

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

09/07/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/29/2021

EX2G

SOU EXTENSION 2 GRANTED

07/27/2021

EXT2

SOU EXTENSION 2 FILED

07/27/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/27/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/12/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/27/2021

EX1G

SOU EXTENSION 1 GRANTED

01/25/2021

EXT1

SOU EXTENSION 1 FILED

01/25/2021

EEXT

SOU TEAS EXTENSION RECEIVED

01/25/2021

DOCK

ASSIGNED TO EXAMINER

01/12/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/09/2020

PUBO

PUBLISHED FOR OPPOSITION

06/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/29/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

04/20/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/20/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

04/20/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/20/2020

DOCK

ASSIGNED TO EXAMINER

04/13/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/27/2020

NWAP

NEW APPLICATION ENTERED

01/27/2020

Continuous trademark protection

Get notified about every new filing that threatens ARGORNA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.